Colorectal cancer in patients with inflammatory bowel disease: can we predict risk? - Wikidata - wikimedia - TriplyDB

Colorectal cancer in patients with inflammatory bowel disease: can we predict risk?

Colorectal cancer in patients with inflammatory bowel disease: can we predict risk?

http://www.wikidata.org/entity/Q36175033

about

Serum inflammatory markers and risk of colorectal cancer in patients with inflammatory bowel diseases.Colonoscopy is associated with a reduced risk for colon cancer and mortality in patients with inflammatory bowel diseases Hyperhomocysteinemia as a potential contributor of colorectal cancer development in inflammatory bowel diseases: a review.Statin Use Is Associated With Reduced Risk of Colorectal Cancer in Patients With Inflammatory Bowel Diseases.Whole-Exome Sequencing Analyses of Inflammatory Bowel Disease-Associated Colorectal Cancers.Panax notoginseng attenuates experimental colitis in the azoxymethane/dextran sulfate sodium mouse model Intestinal microbiota, probiotics and human gastrointestinal cancers.Modern methodologies and tools for human hazard assessment of chemicals Suppression of colitis-associated carcinogenesis through modulation of IL-6/STAT3 pathway by balsalazide and VSL#3.

P2860

Q33857049-2EA4E19D-4F78-4BBC-9596-F532A5A68612 Q34979766-2C577DD2-E70E-46E0-8420-3B7A6FA3189C Q35012018-707FCAB5-6C37-4824-A4D2-C9EFF0CCA53A Q37018514-98778464-75A7-41C4-8278-D580B2488E57 Q37610120-9D6537ED-D615-4117-A871-4F5279B49C8A Q37714511-C8294697-586D-4424-AFED-4868E2B0442B Q38062446-4BC8A9E8-05B3-4879-94B3-DA9D9068D538 Q47154406-C61788F0-007B-4FC7-A068-4B121A90EC16 Q52892251-118ECD3E-F16A-409F-87EB-9A86501F6738

P2860

Colorectal cancer in patients with inflammatory bowel disease: can we predict risk?

http://www.wikidata.org/entity/Q36175033

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Colorectal cancer in patients with inflammatory bowel disease: can we predict risk?

@ast

Colorectal cancer in patients with inflammatory bowel disease: can we predict risk?

@en

type

label

Colorectal cancer in patients with inflammatory bowel disease: can we predict risk?

@ast

Colorectal cancer in patients with inflammatory bowel disease: can we predict risk?

@en

prefLabel

Colorectal cancer in patients with inflammatory bowel disease: can we predict risk?

@ast

Colorectal cancer in patients with inflammatory bowel disease: can we predict risk?

@en

P1433

Q36175033-426463DB-6B74-45C2-8525-1EA25E5D66E0

P1476

Q36175033-C3334DB3-C4B9-43BC-B3EB-29EE297E156D

P2860

Q36175033-18CF7919-1DB5-48A3-B9F8-923F7D36E0A8

Q36175033-1AEC60E4-4F96-440D-8AA2-7C4010BFA2FF

Q36175033-1B1AB1DA-9D2F-4B38-A626-BAE902DA38AA

Q36175033-24E9DBCB-2696-4D84-AEA8-84EA8DE64CB9

Q36175033-2D82073B-0A8C-47E1-A50A-FC7F6BEB11CC

Q36175033-34416BCB-3942-4C91-829C-02E50C1B4D60

Q36175033-3C4D9372-02C4-4977-8D0C-15E59C6C2B54

Q36175033-435E23B0-CB91-4CB5-8541-0BD1941F206F

Q36175033-54C2A7F0-E590-429C-B1EA-BEE89B355BD4

Q36175033-5A46D1C1-4B9F-4AFC-B909-E8FB5EB4A7D4

P304

Q36175033-9D0EB7F5-E263-4F56-A86D-335695D97A0D

P31

Q36175033-BE8EB64F-588C-4462-96C1-F000604C65FC

P356

Q36175033-24D95AC1-1562-473B-BA39-049E558F329F

P407

Q36175033-47E47D94-60B4-4E2D-A996-E1CA53B2E51F

P433

Q36175033-0415E4F4-882C-4309-B3DD-2FBAC969D459

P478

Q36175033-E9481772-8D56-4BBA-B3F8-3F61F5E959B3

P50

Q36175033-2F9EFAF4-1284-4F4A-A100-BCA2E188F6BA

Q36175033-3CB0A550-FBE1-42C7-B5CA-F639A5A99D55

Q36175033-BA0CB03C-03D5-42BC-912F-DBBA1BEF14A5

P577

Q36175033-32891015-1F1E-414A-9C06-5509528AE353

P5875

Q36175033-7FC9F297-FB27-4044-9D2C-EAB541D05114

P698

Q36175033-51954D47-03BE-4E68-AFCD-9C01082CECB9

P921

Q36175033-9C402E58-C9AF-4C7E-B3D5-3244C532E249

Q36175033-D07A2911-ABC8-43BB-AD6F-5C7E59732895

P932

Q36175033-20D14C68-0940-4643-B63C-749F90A890F7

P356

WJG.V18.I31.4091

P1433

World Journal of Gastroenterology

P1476

Colorectal cancer in patients with inflammatory bowel disease: can we predict risk?

@en

P2860

Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease

The risk of colorectal cancer in ulcerative colitis: a meta-analysis

Immunoregulatory mechanisms underlying prevention of colitis-associated colorectal cancer by probiotic bacteria

DNA extraction from paraffin embedded material for genetic and epigenetic analyses.

Mechanisms of intestinal inflammation and development of associated cancers: lessons learned from mouse models.

Cancer risk in IBD: how to diagnose and how to manage DALM and ALM.

Probiotic bacteria produce conjugated linoleic acid locally in the gut that targets macrophage PPAR γ to suppress colitis

Ulcerative colitis and colorectal cancer. A population-based study.

Increased risk of large-bowel cancer in Crohn's disease with colonic involvement.

Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease.

P304

4091-4094

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V18.I31.4091

http://www.w3.org/2001/XMLSchema#string

P407

P433

31

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

Vibeke Andersen

Jonas Halfvarson

P577

2012-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230734035

http://www.w3.org/2001/XMLSchema#string

P698

22919240

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

inflammatory bowel diseases

P932

3422788

http://www.w3.org/2001/XMLSchema#string